V-CHEK™ 2019-nCoV Ag&FLU A/B Combo Rapid Test

    


It is difficult to make an accurate diagnosis of a 2019-novel coronavirus and influenza based on clinical symptoms because the initial symptoms of influenza are similar to many other diseases.Therefore, it can only be confirmed by laboratory diagnostic tests.Early differential diagnosis of 2019-nCoV and influenza A or B may enable appropriate antiviral therapy.Early diagnosis and treatment are particularly valuable in a clinical setting, and accurate diagnosis can help healthcare professionals manage patients with 2019-nCoV and influenza who are at risk of complications.
The 2019-nCoV Ag & FLU A/B Combo Rapid test is an in vitro immunochromatographic assay for the qualitative detection of 2019-nCoV antigen and   influenza A / B antigens in nasal swab specimens collected from patients with signs and symptoms of respiratory infection. This test is intended for use as an aid in the differential diagnosis of 2019-nCoV and influenza A/ B viral infections in humans in conjunction with clinical and epidemiological risk factors.